| Bioactivity | Vipivotide tetraxetan Ligand-Linker Conjugate (PSMA-617 Ligand-Linker Conjugate) is composed of a linker and Glutamate-urea-Lysine, can be used to synthesize Vipivotide tetraxetan (PSMA-617). Glutamate-urea-Lysine is is the selective pharmacophore to bind to prostate specific membrane antigen (PSMA)[1]. | |||||||||
| Name | Vipivotide tetraxetan Ligand-Linker Conjugate | |||||||||
| CAS | 1703768-74-4 | |||||||||
| Formula | C33H45N5O9 | |||||||||
| Molar Mass | 655.74 | |||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | |||||||||
| Storage |
|
Vipivotide tetraxetan Ligand-Linker Conjugate
CAS: 1703768-74-4 F: C33H45N5O9 W: 655.74
Vipivotide tetraxetan Ligand-Linker Conjugate (PSMA-617 Ligand-Linker Conjugate) is composed of a linker and Glutamate-u
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.